NEW YORK (GenomeWeb News) – The life sciences services firm LGC has purchased one of Fluidigm’s BioMark Systems, which it will use to offer genetic analysis services in its United Kingdom labs, Fluidigm said today.
The BioMark System uses fluidic circuit technology to improve throughput, reduce complexity, and allow for use of smaller samples and less reagents in high throughput genotyping applications, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.